Cancer Research Institute (CRI) was founded in 1953 and is the world's leading nonprofit dedicated to funding cancer immunotherapy research. Based in New York City, CRI is committed to extending the lives of cancer patients and reducing cancer-related deaths by fueling the development of smarter, more effective treatments that mobilize the body’s natural immune defenses against all types of cancer.
With a mission to support critical research, invest in the development of promising new treatments, and unite the efforts of the field’s leaders worldwide, Cancer Research Institute is driving a transformation in cancer therapy, enabling patients to live longer, healthier lives free from the fear of cancer.
The nonprofit operates in the Biotechnology and Education industries, and for more information, individuals can visit www.cancerresearch.org.
As of now, there is no available information on the last investment or investors associated with Cancer Research Institute.
There is no investment information
No recent news or press coverage available for Cancer Research Institute (CRI).